Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H
Department of Pharmacology, Nagoya University School of Medicine, Japan.
J Biol Chem. 1990 Mar 15;265(8):4315-20.
1-[N,O-Bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpipera zine (KN-62), a selective inhibitor of rat brain Ca2+/calmodulin-dependent protein kinase II (Ca2+/CaM kinase II) was synthesized and its inhibitory properties in vitro and in vivo were investigated. KN-62 inhibited phosphorylation of exogenous substrate (chicken gizzard myosin 20-kDa light chain) by Ca2+/CaM kinase II with Ki value of 0.9 microM, but no significant effect up to 100 microM on activities of chicken gizzard myosin light chain kinase, rabbit brain protein kinase C, and bovine heart cAMP-dependent protein kinase type II. KN-62 also inhibited the Ca2+/calmodulin-dependent autophosphorylation of both alpha (50 kDa) and beta (60 kDa) subunits of Ca2+/CaM kinase II dose dependently in the presence or absence of exogenous substrate. Kinetic analysis indicated that this inhibitory effect of KN-62 was competitive with respect to calmodulin. However, KN-62 did not inhibit the activity of autophosphorylated Ca2+/CaM kinase II. Moreover, Ca2+/CaM kinase II bound to a KN-62-coupled Sepharose 4B column, but calmodulin did not. These results suggest that KN-62 affects the interaction between calmodulin and Ca2+/CaM kinase II following inhibition of this kinase activity by directly binding to the calmodulin binding site of the enzyme but does not affect the calmodulin-independent activity of already autophosphorylated (activated) enzyme. We examined the effect of KN-62 on cultured PC12 D pheochromocytoma cells. KN-62 suppressed the A23187 (0.5 microM)-induced autophosphorylation of the 53-kDa subunit of Ca2+/CaM kinase in PC12 D cells, which was immunoprecipitated with anti-rat forebrain Ca2+/CaM kinase II polypeptides antibodies coupled to Sepharose 4B, thereby suggesting that KN-62 could inhibit the Ca2+/CaM kinase II activity in vivo.
1-[N,O-双(5-异喹啉磺酰基)-N-甲基-L-酪氨酰基]-4-苯基哌嗪(KN-62),一种大鼠脑Ca2+/钙调蛋白依赖性蛋白激酶II(Ca2+/CaM激酶II)的选择性抑制剂,已被合成,并对其体外和体内的抑制特性进行了研究。KN-62抑制Ca2+/CaM激酶II对外源底物(鸡砂囊肌球蛋白20-kDa轻链)的磷酸化,Ki值为0.9 microM,但在高达100 microM时对鸡砂囊肌球蛋白轻链激酶、兔脑蛋白激酶C和牛心II型cAMP依赖性蛋白激酶的活性无显著影响。在有或没有外源底物的情况下,KN-62还剂量依赖性地抑制Ca2+/CaM激酶II的α(50 kDa)和β(60 kDa)亚基的Ca2+/钙调蛋白依赖性自身磷酸化。动力学分析表明,KN-62的这种抑制作用相对于钙调蛋白是竞争性的。然而,KN-62并不抑制自身磷酸化的Ca2+/CaM激酶II的活性。此外,Ca2+/CaM激酶II与KN-62偶联的琼脂糖4B柱结合,但钙调蛋白不结合。这些结果表明,KN-62通过直接结合到该酶的钙调蛋白结合位点来抑制该激酶活性,从而影响钙调蛋白与Ca2+/CaM激酶II之间的相互作用,但不影响已经自身磷酸化(活化)的酶的不依赖钙调蛋白的活性。我们研究了KN-62对培养的PC12 D嗜铬细胞瘤细胞的影响。KN-62抑制了PC12 D细胞中A23187(0.5 microM)诱导的Ca2+/CaM激酶53-kDa亚基的自身磷酸化,该亚基用与琼脂糖4B偶联的抗大鼠前脑Ca2+/CaM激酶II多肽抗体进行免疫沉淀,从而表明KN-62可以在体内抑制Ca2+/CaM激酶II的活性。